Docgo vs Strata Critical Medical
Docgo is the larger business, with $322m of revenue in fiscal 2025 against $197m for Strata Critical Medical (1.6 times as much). Strata Critical Medical grew faster (34.3% against -47.7%). Strata Critical Medical kept more of each dollar of sales as profit: a net margin of 21.0% against -56.6%.
| Latest fiscal year | DocgoDCGO, 2025 | Strata Critical MedicalSRTA, 2025 |
|---|---|---|
| Revenue | $322m | $197m |
| Revenue growth | -47.7% | 34.3% |
| Net income | −$182m | $41.3m |
| Operating margin | — | — |
| Net margin | -56.6% | 21.0% |
| Return on equity | -78.5% | 16.5% |
| Free cash flow | $29.9m | −$58.5m |
| Cash | $51.0m | $31.0m |
| Total debt | $287,323 | $0 |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $10.8m | $0 |
| Employees | 3,600 | 601 |
| Market value | $25.6m | $383m |
| Price vs our value range | — | — |
| Moat score | 18 (Weak) | 10 (Weak) |
| Insider trades, 12 months | 0 buys, 1 sales | 2 buys, 10 sales |